Doximity (DOCS) Form 144 Shows Insider Sale, 6,000 Shares Sold Recently
Rhea-AI Filing Summary
Form 144 notice for Doximity, Inc. (DOCS): The filer reports a proposed sale of 2,000 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $140,020.00, expected to sell on 10/01/2025 on the NYSE. The securities were acquired on 10/01/2025 by stock option exercise and paid in cash. The filing also discloses three prior sales by the same person in the past three months: 2,000 shares on 09/02/2025 for $133,140.00, 2,000 shares on 08/01/2025 for $114,180.00, and 2,000 shares on 07/01/2025 for $121,920.00. The notice includes the standard Rule 144 signature representation regarding material nonpublic information.
Positive
- None.
Negative
- Insider sales disclosed: The filer sold or proposes to sell 6,000 shares across the past three months and plans an additional 2,000-share sale, which may be viewed unfavorably by some investors.
Insights
TL;DR: Insider sold recently acquired option shares in small, routine blocks; disclosure is standard under Rule 144.
The filing shows a proposed sale of 2,000 shares acquired by stock option exercise and paid in cash, to be executed through Morgan Stanley Smith Barney on the NYSE. The seller recorded three prior monthly sales of identical size during the past three months, indicating ongoing disposals by the same person. From a trading disclosure perspective this is a routine compliance filing and does not, on its face, indicate new company-specific developments or disclosed material nonpublic information.
TL;DR: Transaction appears compliant with Rule 144; multiple recent sales merit monitoring for insider disposition patterns.
The notice certifies the seller lacks undisclosed material information and provides acquisition and payment details consistent with an option exercise followed by planned sale. Repeated monthly sales of 2,000-share blocks are recorded; while fully permissible, such patterns can be relevant to governance oversight and dilution analysis. The filing itself contains the standard attestation language and broker details required for Rule 144 compliance.